The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 09, 2024

Filed:

Aug. 29, 2017
Applicants:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);

The Wistar Institute of Anatomy and Biology, Philadelphia, PA (US);

Inventors:

David Weiner, Merion, PA (US);

Alfredo Perales Puchalt, Philadelphia, PA (US);

Jian Yan, Wallingford, PA (US);

Anna Maria Slager, Lansdale, PA (US);

Assignees:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inovio Pharmaceuticals, Inc., Plymouth Meeting, PA (US);

The Wistar Institute of Anatomy and Biology, Philadelphia, PA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07H 21/02 (2006.01); A61K 39/00 (2006.01); A61K 38/17 (2006.01); A61P 35/00 (2006.01); C07K 14/72 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001102 (2018.08); A61K 38/1796 (2013.01); A61K 39/0011 (2013.01); A61P 35/00 (2018.01); C07K 14/723 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/53 (2013.01); A61K 2039/572 (2013.01); A61K 2039/892 (2018.08);
Abstract

Provided herein is an immunogenic composition comprising a synthetic consensus antigen to Follicle Stimulating Hormone Receptor (FSHR) protein which is abundant in many ovarian cancer sub-types. Also disclosed herein is a method of treating a tumor associated pathology in a subject in need thereof, by administering the immunogenic composition to the subject.


Find Patent Forward Citations

Loading…